首页> 美国卫生研究院文献>Journal of Aerosol Medicine and Pulmonary Drug Delivery >Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth
【2h】

Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth

机译:无创正压通气期间的气雾药物输送:受试者间变异性和赋形生长的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Nebulized aerosol drug delivery during the administration of noninvasive positive pressure ventilation (NPPV) is commonly implemented. While studies have shown improved patient outcomes for this therapeutic approach, aerosol delivery efficiency is reported to be low with high variability in lung-deposited dose. Excipient enhanced growth (EEG) aerosol delivery is a newly proposed technique that may improve drug delivery efficiency and reduce intersubject aerosol delivery variability when coupled with NPPV.>Materials and Methods: A combined approach using in vitro experiments and computational fluid dynamics (CFD) was used to characterize aerosol delivery efficiency during NPPV in two new nasal cavity models that include face mask interfaces. Mesh nebulizer and in-line dry powder inhaler (DPI) sources of conventional and EEG aerosols were both considered.>Results: Based on validated steady-state CFD predictions, EEG aerosol delivery improved lung penetration fraction (PF) values by factors ranging from 1.3 to 6.4 compared with conventional-sized aerosols. Furthermore, intersubject variability in lung PF was very high for conventional aerosol sizes (relative differences between subjects in the range of 54.5%–134.3%) and was reduced by an order of magnitude with the EEG approach (relative differences between subjects in the range of 5.5%–17.4%). Realistic in vitro experiments of cyclic NPPV demonstrated similar trends in lung delivery to those observed with the steady-state simulations, but with lower lung delivery efficiencies. Reaching the lung delivery efficiencies reported with the steady-state simulations of 80%–90% will require synchronization of aerosol administration during inspiration and reducing the size of the EEG aerosol delivery unit.>Conclusions: The EEG approach enabled high-efficiency lung delivery of aerosols administered during NPPV and reduced intersubject aerosol delivery variability by an order of magnitude. Use of an in-line DPI device that connects to the NPPV mask appears to be a convenient method to rapidly administer an EEG aerosol and synchronize the delivery with inspiration.
机译:>背景:通常在无创正压通气(NPPV)给药过程中采用雾化气雾剂给药。尽管研究表明采用这种治疗方法可改善患者的预后,但据报道,其气雾传递效率较低,并且肺沉积剂量存在较大差异。赋形增强生长(EEG)气雾剂输送是一项新提出的技术,当与NPPV结合使用时,可提高药物输送效率并降低受试者间气雾剂输送的变异性。>材料和方法:流体动力学(CFD)用于在两个新的包含面罩界面的鼻腔模型中表征NPPV期间的气溶胶输送效率。 >结果:基于经过验证的稳态CFD预测,EEG气雾剂的输送改善了肺渗透分数(PF),同时考虑了网状雾化器和在线干粉吸入器(DPI)来源。与常规尺寸的气溶胶相比,其数值范围为1.3到6.4。此外,常规气雾剂大小的肺PF的受试者间变异性非常高(受试者之间的相对差异在54.5%–134.3%范围内),而通过EEG方法将受试者PF之间的变异性降低了一个数量级(受试者之间的相对差异在5.5%–17.4%)。现实的循环NPPV体外实验表明,与稳态模拟观察到的情况相比,肺部输送的趋势相似,但肺部输送效率较低。要达到稳态模拟所报告的80%–90%的肺部输送效率,就需要在吸气期间同步进行气雾剂给药并减小EEG气雾剂输送装置的尺寸。>结论:启用了EEG方法在NPPV期间对肺气雾剂进行高效肺部输送,并使受试者间气雾剂输送变异性降低了一个数量级。使用连接到NPPV面罩的在线DPI设备似乎是一种快速管理EEG气雾剂并使呼吸与吸气同步的便捷方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号